Basic Searches
Searches without any special characters (listed below) will return items that contain the exact value(s) entered in the search field. This means that searching for "ASPIRIN CALCIUM" won't return any items that have "ASPIRIN GLYCINE CALCIUM" because the search term doesn't match exactly.
Boolean Operators
OR - searches with terms separated by " OR " will return items that contain any of the terms in the search.
Example: "ASPIRIN" OR "CALCIUM" will return items that have strings like "ASPIRIN GLYCINE" and "GLYCINE CALCIUM" because they contain at least one of the terms in the search.

AND - searches with terms separated by " AND " will return items that contain all the terms in the search.
Example: "ASPIRIN" AND "CALCIUM" won't return items that have strings "ASPIRIN GLYCINE" and "GLYCINE CALCIUM" because neither contain both terms, but it will return "ASPIRIN GLYCINE CALCIUM" because it contains both search terms.
version 2.7.1
Substance Class Protein
Protein Type RECEPTOR
Protein Sub Type
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
50U1BO5G5P
Record Status Validated
Record Version
Show Definitional References Hide Definitional References
Download
Name Type Language Details Access References
ALPHA-2A ADRENERGIC RECEPTOR
Common Name
English  
ALPHA-2AAR
Common Name
English  
ALPHA-2A ADRENORECEPTOR
Common Name
English  
ALPHA-2 ADRENERGIC RECEPTOR SUBTYPE C10
Common Name
English  
ADRA2A
Common Name
English  
Code System Code Type Description Access References
FDA UNII
50U1BO5G5P
Created by admin on Wed Aug 04 22:15:54 EDT 2021 , Edited by admin on Wed Aug 04 22:15:54 EDT 2021
PRIMARY
PHAROS
P08913
Created by admin on Wed Aug 04 22:15:54 EDT 2021 , Edited by admin on Wed Aug 04 22:15:54 EDT 2021
PRIMARY
UNIPROT
P08913
Created by admin on Wed Aug 04 22:15:54 EDT 2021 , Edited by admin on Wed Aug 04 22:15:54 EDT 2021
PRIMARY
WIKIPEDIA
ALPHA-2_ADRENERGIC_RECEPTOR#INDIVIDUAL
Created by admin on Wed Aug 04 22:15:54 EDT 2021 , Edited by admin on Wed Aug 04 22:15:54 EDT 2021
PRIMARY
From To
1_106 1_188
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_10
N 1_14
Related Record Type Details Access References
AGONIST -> TARGET
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 22:16:10 EDT 2021 , Edited by admin on Wed Aug 04 22:16:10 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:09 EDT 2021 , Edited by admin on Wed Aug 04 22:16:09 EDT 2021
AGONIST -> TARGET
none
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:55 EDT 2021 , Edited by admin on Wed Aug 04 22:15:55 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:59 EDT 2021 , Edited by admin on Wed Aug 04 22:15:59 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:08 EDT 2021 , Edited by admin on Wed Aug 04 22:16:08 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:58 EDT 2021 , Edited by admin on Wed Aug 04 22:15:58 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:56 EDT 2021 , Edited by admin on Wed Aug 04 22:15:56 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:54 EDT 2021 , Edited by admin on Wed Aug 04 22:15:54 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:06 EDT 2021 , Edited by admin on Wed Aug 04 22:16:06 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:55 EDT 2021 , Edited by admin on Wed Aug 04 22:15:55 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:04 EDT 2021 , Edited by admin on Wed Aug 04 22:16:04 EDT 2021
AGONIST -> TARGET
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 22:16:10 EDT 2021 , Edited by admin on Wed Aug 04 22:16:10 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:09 EDT 2021 , Edited by admin on Wed Aug 04 22:16:09 EDT 2021
AGONIST -> TARGET
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 22:16:10 EDT 2021 , Edited by admin on Wed Aug 04 22:16:10 EDT 2021
AGONIST -> TARGET
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 22:16:10 EDT 2021 , Edited by admin on Wed Aug 04 22:16:10 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:57 EDT 2021 , Edited by admin on Wed Aug 04 22:15:57 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:09 EDT 2021 , Edited by admin on Wed Aug 04 22:16:09 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:58 EDT 2021 , Edited by admin on Wed Aug 04 22:15:58 EDT 2021
RADIOLIGAND->TARGET
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 22:16:10 EDT 2021 , Edited by admin on Wed Aug 04 22:16:10 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:02 EDT 2021 , Edited by admin on Wed Aug 04 22:16:02 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:03 EDT 2021 , Edited by admin on Wed Aug 04 22:16:03 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:09 EDT 2021 , Edited by admin on Wed Aug 04 22:16:09 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:09 EDT 2021 , Edited by admin on Wed Aug 04 22:16:09 EDT 2021
AGONIST -> TARGET
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 22:15:54 EDT 2021 , Edited by admin on Wed Aug 04 22:15:54 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:02 EDT 2021 , Edited by admin on Wed Aug 04 22:16:02 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:59 EDT 2021 , Edited by admin on Wed Aug 04 22:15:59 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:06 EDT 2021 , Edited by admin on Wed Aug 04 22:16:06 EDT 2021
ACTIVATOR -> TARGET
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 22:16:11 EDT 2021 , Edited by admin on Wed Aug 04 22:16:11 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:55 EDT 2021 , Edited by admin on Wed Aug 04 22:15:55 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:55 EDT 2021 , Edited by admin on Wed Aug 04 22:15:55 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:08 EDT 2021 , Edited by admin on Wed Aug 04 22:16:08 EDT 2021
INHIBITOR -> TARGET
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 22:16:11 EDT 2021 , Edited by admin on Wed Aug 04 22:16:11 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:09 EDT 2021 , Edited by admin on Wed Aug 04 22:16:09 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:05 EDT 2021 , Edited by admin on Wed Aug 04 22:16:05 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:10 EDT 2021 , Edited by admin on Wed Aug 04 22:16:10 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:08 EDT 2021 , Edited by admin on Wed Aug 04 22:16:08 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:57 EDT 2021 , Edited by admin on Wed Aug 04 22:15:57 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:01 EDT 2021 , Edited by admin on Wed Aug 04 22:16:01 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:55 EDT 2021 , Edited by admin on Wed Aug 04 22:15:55 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:04 EDT 2021 , Edited by admin on Wed Aug 04 22:16:04 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:57 EDT 2021 , Edited by admin on Wed Aug 04 22:15:57 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:04 EDT 2021 , Edited by admin on Wed Aug 04 22:16:04 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:15:58 EDT 2021 , Edited by admin on Wed Aug 04 22:15:58 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:05 EDT 2021 , Edited by admin on Wed Aug 04 22:16:05 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:06 EDT 2021 , Edited by admin on Wed Aug 04 22:16:06 EDT 2021
AGONIST -> TARGET
Mediator Substance Details
none
SHORT-ACTING
Created by admin on Wed Aug 04 22:16:06 EDT 2021 , Edited by admin on Wed Aug 04 22:16:06 EDT 2021
Structural Modifications
Modification Type Location Site Location Type Residue Modified Extent Modification Name Modification ID Access
AMINO ACID SUBSTITUTION [1_331] DEXFOSFOSERINE VI4F0K069V
Name Property Type Amount Referenced Substance Defining Parameters Access References
MOL_WEIGHT CHEMICAL
0
Created Wed Aug 04 22:15:53 EDT 2021
Created By admin
Last Edited Wed Aug 04 22:15:53 EDT 2021
Last Edited By admin
Index Source Text / Citation Source Type Tags Date Accessed File Access
1 Br J Ophthalmol. 2005 Jun; 89(6): 758–763 JA
2 dump-public-2021-07-22_UPDATED.gsrs BATCH_IMPORT Wed Aug 04 22:15:52 EDT 2021
3 WIK WIKI NOMEN PUBLIC_DOMAIN_RELEASE
4 SRS CODE IMPORT SRS NOMEN Fri Apr 28 15:32:49 EDT 2017
5 UNIPROT UNIPROT NOMEN
6 Corena-McLeod, Maria. "Comparative pharmacology of risperidone and paliperidone." Drugs in R&D 15.2 (2015): 163-174. JA
7 Gulati, Anil, et al. "Clinical Results Indicating Effectiveness of PMZ-2010 (Centhaquin) as a Novel Resuscitative Agent for Hypovolemic Shock." Circulation 138.Suppl_1 (2018): A13092-A13092. CLINICAL_TRIALS.GOV NOMEN PUBLIC_DOMAIN_RELEASE
8 stn SRS NOMEN
9 ADISINSIGHT WEBSITE NOMEN PUBLIC_DOMAIN_RELEASE
10 https://en.wikipedia.org/wiki/Norepinephrine WEBSITE NOMEN
11 SRS import [50U1BO5G5P] SRS NOMEN Fri Apr 28 15:32:49 EDT 2017
12 WIKI WIKI NOMEN PUBLIC_DOMAIN_RELEASE
13 http://www.uniprot.org/uniprot/P08913 SRS NOMEN PUBLIC_DOMAIN_RELEASE AUTO_SELECTED
14 https://en.wikipedia.org/wiki/Alpha-2_adrenergic_receptor WEBSITE NOMEN
15 https://en.wikipedia.org/wiki/Beta-1_adrenergic_receptor WEBSITE NOMEN
16 https://en.wikipedia.org/wiki/Alpha-2_adrenergic_receptor#Individual WEBSITE NOMEN